Sun Pharmaceutical Industries Limited
Shareholders meeting
01 / The disclosure
What the company shared
Notice of Postal Ballot October 2026
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
The evidence
Read the source excerpts
01Approval of Secondary Acquisition of Equity Shares by the Trust 3.
Page 1
02IST Announcement of V oting Results On or before Tuesday, 03 November 2026
Page 1
03Explanatory Statement • Part A – Sun Pharma Employees Stock Option Plan (ESOP 2026) and Connected Matters • Part B - Funding and Acquisition and Connected Matters 10-23 4.
Page 2
04The proposals cover adoption of ESOP 2026, acquisition of shares through a Trust for implementation of the Plan and extension of the Plan to eligible employees of subsidiary company(ies).
Page 3
05The Plan will be implemented using existing shares acquired from the secondary market and will not involve a fresh issue of shares by the Company thereby not involving any dilution.
Page 3
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106805399
- First collected
- 3 Oct 2026, 17:17 IST
- PDF extraction
- extracted · 3 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- d3fa48e8b8fd6a63fff26cb9a75d0622926c014b3dba9a0cdbb51616f38118ca